...
首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Design of attachment type of drug delivery system by complex formation of avidin with biotinyl drug model and biotinyl saccharide
【24h】

Design of attachment type of drug delivery system by complex formation of avidin with biotinyl drug model and biotinyl saccharide

机译:亲和素与生物素基药物模型和生物素基糖类复合形成的药物传递系统的附着类型设计

获取原文
获取原文并翻译 | 示例
           

摘要

Recent studies have focused on the active targeting of drug delivery by combining a homing device and antitumor drug. For this purpose, synthesis of a well-designed vehicle (such as polymer/drug conjugates or nanoparticles) carrying a drug and a homing device requires many steps. We propose a new type of drug delivery system (DDS) by formation of a complex containing avidin (Av) plus biotinyl drug with a biotinyl homing device, which easily accommodates the combination of various drugs and homing devices. The targetable drug complex can be prepared by selecting an appropriate biotinyl drug derivative and a biotinyl homing device and mixing them with avidin. Fluorescent dye with 5-(and-6)-carboxytetramethylrhodamine (TAMRA) was used as a drug model, and galactose (Gal) recognized by liver parenchymal cells was used as a homing device. TAMRA and galactose were attached to biotin (Bio) through a triethyleneglycol (TEG) spacer group to give Bio-TEG-TAMRA conjugate and Bio-TEG-Gal conjugate, respectively. Confocal laser scanning microscopic studies suggest that the complexes prepared by mixing Bio-TEG-Gal conjugate and fluorescein isothiocyanate (FITC)-labeted Av (feed molar ratio 4:1), and mixing Bio-TEG-Gal conjugate, Bio-TEG-TAMRA conjugate and FITC-labeled Av are internalized into the hepatoma cells through a receptor-mediated endocytosis mechanism. (C) 2003 Elsevier B.V. All rights reserved.
机译:最近的研究集中在通过结合归巢装置和抗肿瘤药物来主动靶向药物递送。为此,携带药物和归巢装置的设计良好的载体(例如聚合物/药物缀合物或纳米颗粒)的合成需要许多步骤。我们提出了一种新型的药物递送系统(DDS),该方法是通过形成包含生物素基归位装置的包含抗生物素蛋白(Av)加上生物素基药物的复合物,该复合物可以轻松容纳各种药物和归位装置的组合。可通过选择合适的生物素药物衍生物和生物素归巢装置并将它们与抗生物素蛋白混合来制备可靶向药物复合物。具有5-(和-6)-羧基四甲基罗丹明(TAMRA)的荧光染料被用作药物模型,被肝实质细胞识别的半乳糖(Gal)被用作归巢装置。 TAMRA和半乳糖通过三乙二醇(TEG)间隔基团连接到生物素(Bio)上,分别得到Bio-TEG-TAMRA共轭物和Bio-TEG-Gal共轭物。共聚焦激光扫描显微镜研究表明,通过混合Bio-TEG-Gal共轭物和异硫氰酸荧光素(FITC)制成的Av(进料摩尔比为4:1),并混合Bio-TEG-Gal共轭物,Bio-TEG-TAMRA,可以制备复合物偶联物和FITC标记的Av通过受体介导的内吞机制被内化到肝癌细胞中。 (C)2003 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号